-
Product Insights
Familial Adenomatous Polyposis – Drugs In Development, 2023
Global Markets Direct’s, ‘Familial Adenomatous Polyposis - Drugs In Development, 2023’, provides an overview of the Familial Adenomatous Polyposis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Familial Adenomatous Polyposis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Charcot-Marie-Tooth Disease Type I A – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type I A - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease Type I A pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type I A, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Osteogenesis Imperfecta – Drugs In Development, 2023
Global Markets Direct’s, ‘Osteogenesis Imperfecta - Drugs In Development, 2023’, provides an overview of the Osteogenesis Imperfecta pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteogenesis Imperfecta, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Wilson Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Wilson Disease - Drugs In Development, 2023’, provides an overview of the Wilson Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Wilson Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Alport Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Alport Syndrome - Drugs In Development, 2023’, provides an overview of the Alport Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Alport Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Charcot-Marie-Tooth Disease Type II – Drugs In Development, 2023
Global Markets Direct’s, ‘Charcot-Marie-Tooth Disease Type II - Drugs In Development, 2023’, provides an overview of the Charcot-Marie-Tooth Disease Type II pipeline landscape. The report provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type II, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...